SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-084687
Filing Date
2021-06-23
Accepted
2021-06-23 17:08:54
Documents
6
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2120433d1_6k.htm 6-K 13867
2 EXHIBIT 99.1 tm2120433d1_ex99-1.htm EX-99.1 19862
3 EXHIBIT 99.2 tm2120433d1_ex99-2.htm EX-99.2 1239077
4 EXHIBIT 99.3 tm2120433d1_ex99-3.htm EX-99.3 21870
5 GRAPHIC tm2120433d1_ex99-1img001.jpg GRAPHIC 6560
6 GRAPHIC tm2120433d1_ex99-3img001.jpg GRAPHIC 5631
  Complete submission text file 0001104659-21-084687.txt   1312772
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 211039411
SIC: 2836 Biological Products, (No Diagnostic Substances)